Paper28295628
Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
Georgatzakou HT and 8 others. Eur J Haematol, 2017. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy. Papers, record 28295628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28295628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocytes | Major topic |
| Erythropoietin | Major topic |
| Kidney Failure, Chronic | Major topic |
| Recombinant Proteins | Major topic |
| Renal Dialysis | Major topic |
| Aged | |
| Aged, 80 and over | |
| CD47 Antigen | |
| CD59 Antigens | |
| Case-Control Studies | |
| Cell Shape | |
| Clusterin | |
| Erythrocyte Count | |
| Extracellular Vesicles | |
| Female | |
| Gene Expression | |
| Hemoglobins | |
| Humans | |
| Male | |
| Osmotic Fragility | |
| Treatment Outcome | |
| Uric Acid |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40643488 | Red Cell Death in Renal Disease: The Role of Eryptosis in CKD and Dialysis Patients. | Cells | 2025 | https://conductscience.org/library/papers/40643488 | PubMed |
| 39895569 | Comparison of Urinary Red Blood Cell Distribution (URD) and Dysmorphic Red Blood Cells for Detecting Glomerular Hematuria: A Multicenter Study. | J Clin Lab Anal | 2025 | https://conductscience.org/library/papers/39895569 | PubMed |
| 34707698 | CD47 (Cluster of Differentiation 47). | Atlas Genet Cytogenet Oncol Haematol | 2021 | https://conductscience.org/library/papers/34707698 | PubMed |
| 34572522 | Coagulation Abnormalities in Renal Pathology of Chronic Kidney Disease: The Interplay between Blood Cells and Soluble Factors. | Biomolecules | 2021 | https://conductscience.org/library/papers/34572522 | PubMed |
| 32351956 | The Multi-Faced Extracellular Vesicles in the Plasma of Chronic Kidney Disease Patients. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32351956 | PubMed |
| 31217925 | The role of hormones in renal disease and ischemia-reperfusion injury. | Iran J Basic Med Sci | 2019 | https://conductscience.org/library/papers/31217925 | PubMed |
| 30123081 | Neutrophil Elastase Inhibitors and Chronic Kidney Disease. | Int J Biol Sci | 2018 | https://conductscience.org/library/papers/30123081 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD47 | 961 | PubTator's text mining | https://conductscience.org/library/genes/961 | NCBI Gene |
| CD59 | 966 | PubTator's text mining | https://conductscience.org/library/genes/966 | NCBI Gene |
| CLU | 1191 | PubTator's text mining | https://conductscience.org/library/genes/1191 | NCBI Gene |
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28295628
GET https://conductscience.org/api/papers/v1/28295628/authors